GWM
PETS icon

Geneos Wealth Management’s PetMed Express PETS Stock Holding History

Geneos Wealth Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-450
Closed -$4.61K – 2154
2023
Q3 		$4.61K Sell
450
-755
-63% -$9.32K ﹤0.01% 1767
2023
Q2 		$16.6K Buy
1,205
+755
+168% +$11.3K ﹤0.01% 1430
2023
Q1 		$7.31K Sell
450
-755
-63% -$14.2K ﹤0.01% 1632
2022
Q4 		$21.3K Hold
1,205
– – ﹤0.01% 1324
2022
Q3 		$23K Sell
1,205
-2,030
-63% -$43.1K ﹤0.01% 1274
2022
Q2 		$63K Buy
3,235
+450
+16% +$10.1K ﹤0.01% 1183
2022
Q1 		$71K Hold
2,785
– – ﹤0.01% 1223
2021
Q4 		$70K Sell
2,785
-729
-21% -$20.2K ﹤0.01% 1326
2021
Q3 		$93K Buy
3,514
+1,098
+45% +$31.6K ﹤0.01% 1206
2021
Q2 		$78K Sell
2,416
-1,144
-32% -$36.3K ﹤0.01% 1266
2021
Q1 		$104K Hold
3,560
– – ﹤0.01% 1291
2020
Q4 		$121K Sell
3,560
-235
-6% -$7.24K ﹤0.01% 1052
2020
Q3 		$117K Buy
3,795
+1,890
+99% +$62.6K 0.01% 876
2020
Q2 		$69K Hold
1,905
– – ﹤0.01% 1075
2020
Q1 		$50K Buy
1,905
+900
+90% +$23.6K ﹤0.01% 1110
2019
Q4 		$23K Hold
1,005
– – ﹤0.01% 1624
2019
Q3 		$17K Sell
1,005
-775
-44% -$12.8K ﹤0.01% 1682
2019
Q2 		$27K Sell
1,780
-435
-20% -$8.56K ﹤0.01% 1489
2019
Q1 		$50K Buy
2,215
+1,690
+322% +$38.1K ﹤0.01% 1142
2018
Q4 		$12K Hold
525
– – ﹤0.01% 1726
2018
Q3 		$17K Hold
525
– – ﹤0.01% 1656
2018
Q2 		$23K Hold
525
– – ﹤0.01% 1392
2018
Q1 		$21K Hold
525
– – ﹤0.01% 1378
2017
Q4 		$23K Hold
525
– – ﹤0.01% 1331
2017
Q3 		$17K Hold
525
– – ﹤0.01% 1387
2017
Q2 		$21K Hold
525
– – ﹤0.01% 1257
2017
Q1 		$10K Hold
525
– – ﹤0.01% 1487
2016
Q4 		$12K Hold
525
– – ﹤0.01% 1385
2016
Q3 		$10K Hold
525
– – ﹤0.01% 1371
2016
Q2 		$9K Hold
525
– – ﹤0.01% 1370
2016
Q1 		$9K Buy
+525
New +$8.99K ﹤0.01% 1350

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneos Wealth Management's PETS Position: Q4 2023 in Review

Geneos Wealth Management sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 450 shares — an estimated $4.61K sold.

Geneos Wealth Management first reported a position in PETS in Q1 2016 and held it in 31 quarters. The position peaked at $121K in Q4 2020. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

  • Geneos Wealth Management reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 450 PetMed Express shares in Q4 2023, an estimated $4.61K.
  • Geneos Wealth Management first reported a position in PetMed Express in Q1 2016 and held it in 31 quarters.
  • Geneos Wealth Management's PetMed Express position peaked at $121K in Q4 2020.
  • 130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.